Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 05.12.2025 GMAY.LN IE000P0FL8E3 1,000,002.00 USD  38,109,281.90   38.109  ...

TÜBINGEN, Deutschland--(BUSINESS WIRE)--Nur wenige Monate nach der weltweit ersten gastrischen Mukosaablation (GMA) mit MOVIVA® am Policlinico Universitario Agostino Gemelli in Rom verbreitet sich dieses klinische Verfahren rasch in ganz Europa. Mit rund 80 Eingriffen innerhalb kürzester Zeit in acht Ländern leitet MOVIVA® angesichts des andauernden weltweiten Anstiegs der Adipositas Erkrankungen mit einer minimalinvasiven Option eine neue Ära der endoskopischen bariatrischen Behandlung ein. Ei...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 05.12.2025 FTMO.LN IE000CY30YV9 2,950,002.00 USD  73,516,099.53   24.921  ...

SAN CARLOS, California--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), un’azienda operante nel settore oncologico a livello globale, oggi ha annunciato che alla 67esima edizione del Congresso Annuale della American Society of Hematology (ASH) tenutosi a Orlando, Florida sono stati presentati nuovi dati su sonrotoclax, un inibitore BCL2 di nuova generazione in fase di sperimentazione, che mostrano un significativo beneficio clinico sia in monoterapia sia in combin...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 05.12.2025 SDVI.LN IE000YVOQ2A3   40,361.00 USD   1,055,069.22   26.141  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 05.12.2025 SDVY.LN IE0001R850E1 10,879,007.00 USD 249,426,820.94   22.927  ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), een internationaal oncologiebedrijf, maakte vandaag nieuwe gegevens bekend over sonrotoclax, een onderzoeks-BCL2-remmer van de nieuwe generatie, die belangrijk klinisch voordeel aantoonden als monotherapie en in combinatie bij behandeling van B-cel maligniteiten. Deze gegevens werden voorgesteld tijdens de 67e Annual Meeting & Exposition van de ASH (American Society of Hematology) in Orlando,...

OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive Officer (“CEO”). Francis will join the Company and the Board as an Executive Director on 2 March 2026. Francis brings more than 20 years of experience leading multi-billion-dollar life science businesses, with a strong track record of scaling innovation-driven organisati...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 05.12.2025 FTGS.LN IE000YZLMXT9   25,002.00 USD    558,469.31   22.337  ...

LONDON--(BUSINESS WIRE)--  08 December 2025 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 05 December 2025, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Peel Hunt LLP (“Peel H...